Add BrightSurf on Google Email

Enhanced brain cells clear away dementia-related proteins

Researchers at WashU Medicine have developed a new cellular immunotherapy that uses brain cells called astrocytes to clear away dementia-related proteins, such as amyloid beta. The treatment requires just a single injection and has shown promise in mice by reducing the amount of plaques in half.

SourceWashU Medicine·JournalScience·TypeExperimental study·DateMar 5, 2026

Novel markers of brain blood flow and oxygenation may offer early clues to Alzheimer’s risk

Researchers found that noninvasive measures of brain blood flow and oxygenation are associated with hallmark brain changes in older adults with and without cognitive impairment. Higher values on these indicators were linked to lower levels of amyloid plaques and larger hippocampal volume, indicating a lower risk of Alzheimer's disease.

SourceKeck School of Medicine of USC·TypeExperimental study·DateFeb 23, 2026

Houston Methodist research reveals how the eyes may be a window into early Alzheimer’s detection

A new study from Houston Methodist suggests that the outer area of the retina may hold clues to early Alzheimer's detection, potentially allowing for non-invasive diagnosis and monitoring. Researchers found that changes in retinal cells and blood vessels can indicate the onset of AD years before symptoms appear.

SourceHouston Methodist·JournalJournal of Alzheimer’s Disease·TypeExperimental study·DateFeb 19, 2026

Discover a new ‘cellular target’ to understand and treat alzheimer’s disease

Researchers have identified astrocytes as a promising cellular target for Alzheimer's therapy. Senescent astrocytes, which lose functional capacity, are found in Alzheimer's patients' brains, leading to neuronal damage and inflammation. The study opens an avenue for therapeutic strategies like senolytic drugs.

SourceUniversity of Malaga·JournalJournal of Neuroinflammation·TypeExperimental study·DateFeb 16, 2026

Cumulative lead exposure linked to increased Alzheimer’s and dementia risk, University of Michigan study finds

Researchers at the University of Michigan School of Public Health found a strong association between bone lead concentrations and increased risk of dementia. The study analyzed data from over 30 years of follow-up and estimated cumulative lifetime exposure to lead using machine learning algorithms.

SourceUniversity of Michigan School of Public Health·JournalAlzheimer’s & Dementia·DateFeb 12, 2026

Opening a new window on the brainstem, AI algorithm enables tracking of its vital white matter pathways

A new software tool developed by MIT researchers can reliably and finely resolve eight distinct nerve bundles in live diffusion MRI scans, shedding light on neurodegenerative diseases like Parkinson's and Alzheimer's. The BrainStem Bundle Tool (BSBT) reveals distinct patterns of structural changes in patients with these conditions.

SourcePicower Institute at MIT·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateFeb 9, 2026

Battling the other 'Alzheimer's protein': Studies ID a novel way to stop toxic tau

Scientists have discovered a new strategy to prevent the formation of toxic tau tangles in brain cells, which are linked to neurodegenerative diseases. By targeting polyserine, an amino acid chain that drives tau misfolding, researchers have found a potential preventative treatment for tauopathies.

SourceUniversity of Colorado at Boulder·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateFeb 3, 2026

Aging brains pile up damaged proteins

Researchers at Stanford University discovered that aging brains struggle with protein disposal, leading to the accumulation of damaged proteins in synaptic connections. This finding sheds light on the mechanisms behind neurodegenerative diseases and may lead to new insights into human brain aging.

SourceStanford University·JournalNature·TypeExperimental study·DateFeb 2, 2026

A new molecular atlas of tau enables precision diagnostics and drug targeting across neurodegenerative diseases

Researchers at Boston Children's Hospital have developed a novel mass spectrometry tool called FLEXITau to analyze brain tissue from 203 patients with various tauopathies. The study identified 145 post-translational modifications and 195 cleavage sites across tau, providing a precise molecular roadmap for diagnostics and drug development.

DAC expands early detection implementation network to advance early detection of cognitive impairment in primary care settings

Two U.S. healthcare systems, Tufts Medicine and University of Utah Health, will implement the DAC-SP Early Detection Blueprint across ten primary care sites to improve early detection of cognitive impairment and Alzheimer's disease. The initiative aims to refine a replicable model for early detection that can be adopted nationwide.

How your lifestyle can affect your risk of dementia

A new study from Lund University finds that modifiable risk factors like smoking and high blood pressure can damage brain blood vessels and increase dementia risk. Living a healthy lifestyle may help delay symptom onset in Alzheimer's disease.

SourceLund University·JournalThe Journal of Prevention of Alzheimer s Disease·TypeCase study·DateJan 28, 2026

USC scientists identify promising new target for Alzheimer’s-linked brain inflammation

A multidisciplinary team at USC has developed selective compounds that inhibit an enzyme tied to brain inflammation in people at genetic risk for Alzheimer’s. The inhibitors preserve normal brain function and cross the blood-brain barrier, suggesting a promising therapeutic approach for neurodegenerative diseases.

SourceKeck School of Medicine of USC·Journalnpj Drug Discovery·TypeExperimental study·DateJan 23, 2026

Brain network disorders study provides insights into the role of molecular chaperones in neurodegenerative diseases

A study reviews decades of research on Hsp70's role in neurodegenerative diseases, highlighting its protective effects and potential therapeutic value. The review reveals that different Hsp70 isoforms interact with co-chaperones and cellular pathways to determine protein clearance.

SourceBrain Network Disorders Editorial Office·JournalBrain Network Disorders·TypeLiterature review·DateJan 22, 2026

Itaconate modifications: mechanisms and applications

Researchers summarize itaconate biology highlighting its chemical reactivity and therapeutic potential in treating infectious diseases, sepsis, autoimmunity, neurodegenerative disorders. Itaconate exerts biological effects through post-translational modifications, altering protein activity and signaling pathways

SourceJournal of Intensive Medicine·JournalJournal of Intensive Medicine·TypeLiterature review·DateJan 15, 2026

Understanding sex-based differences and the role of bone morphogenetic protein signaling in Alzheimer’s disease

A study found that increased bone morphogenetic protein signaling is linked to impaired neurogenesis in Alzheimer's disease, particularly in female mice. The research suggests that activation of BMP signaling may be a key factor contributing to the sex-based differences observed in AD.

SourceWaseda University·JournalBiology of Sex Differences·TypeExperimental study·DateJan 9, 2026

Innovative review reveals overlooked complexity in cellular energy sensor's dual roles in Alzheimer's disease

A comprehensive review synthesizes emerging evidence on AMPKα isoforms' dual roles in Alzheimer's disease. The analysis proposes that this complexity may explain why pharmacological approaches have yielded mixed results in treating the disease. Isoform-specific targeting is proposed as a novel therapeutic strategy.

SourceGenomic Press·JournalBrain Medicine·TypeLiterature review·DateJan 6, 2026

40-Hz auditory stimulation shows long-term efficacy in aged monkeys, offering potential for non-invasive Alzheimer's therapy

Researchers demonstrated that 40-Hz auditory stimulation significantly elevates beta-amyloid levels in the cerebrospinal fluid of aged rhesus monkeys, with effects persisting for over five weeks. The study provides evidence supporting 40-Hz stimulation as a non-invasive therapy for Alzheimer's disease.

SourceChinese Academy of Sciences Headquarters·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateJan 5, 2026

New study shows Alzheimer’s disease can be reversed in animal models to achieve full neurological recovery, not just prevented or slowed

Researchers have successfully reversed Alzheimer's disease in animal models by restoring the brain's energy balance, leading to both pathological and functional recovery. The study used preclinical mouse models and human AD brains to show that maintaining proper NAD+ levels can prevent and even reverse the disease.

SourceUniversity Hospitals Cleveland Medical Center·JournalCell Reports Medicine·DateDec 23, 2025

Menopause hormone therapy does not appear to impact dementia risk

A comprehensive review of prior research found no evidence that menopause hormone therapy increases or decreases dementia risk in post-menopausal women. The study included data from over 1 million participants and analyzed the impact on mild cognitive impairment and Alzheimer's disease, with no significant association found.

SourceUniversity College London·JournalThe Lancet Healthy Longevity·TypeSystematic review·DateDec 22, 2025